Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study.

about

Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study.

Item

http://www.wikidata.org/entity/Q48194563

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study.

@en

Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study.

@nl

type

Item

label

Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study.

@en

Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study.

@nl

prefLabel

Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study.

@en

Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study.

@nl

P1476

Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study.

@en

P2093

Helle Holst

http://www.w3.org/2001/XMLSchema#string

Lise Darling

http://www.w3.org/2001/XMLSchema#string

P2860

The history of attention deficit hyperactivity disorder

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

Premarket safety and efficacy studies for ADHD medications in children

A method for estimating the probability of adverse drug reactions

Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects.

A systematic review of the safety of lisdexamfetamine dimesylate.

Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug.

European guidelines on managing adverse effects of medication for ADHD.

The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies

Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder

P2888

s40263-015-0246-y

P304

415-423

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40263-015-0246-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Melissa Voigt Hansen

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25920467

http://www.w3.org/2001/XMLSchema#string